ARTHROPLASTY
Transdermal fentanyl patch reduces pain with movement & improves function after TKA
Arch Orthop Trauma Surg. 2015 Sep;135(9):1291-752 patients undergoing primary total knee arthroplasty (TKA) were randomly assigned to receive a transdermal fentanyl patch (TFP; 12.5ug/h) in conjunction with non-steroidal anti-inflammatory drugs (NSAIDs) or NSAIDs alone for the management of post-operative knee pain. The purpose of this study was to investigate the effect of a transdermal fentanyl patch on pain and function up to 14 days following surgery. Patients receiving treatment with a TFP patch demonstrated greater reduction in VAS pain on movement and greater muscle strength recovery at 14 days compared to patients receiving NSAIDs alone. No significant difference in adverse events (nausea and constipation), VAS pain at rest, or knee range of motion at 14 days was observed between groups.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
